Odd Terje Brustugun

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Tyrosine Kinase

Small Cell Lung Cancer

Top Venues

Acta oncologica (Stockholm, Sweden)

Clinical and experimental medicine

Scandinavian journal of immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Anne Pernille Harlem Dyrbekk, Abdirashid Ali Warsame, Pål Suhrke, Marianne Odnakk Ludahl, Nermin Zecic, Joakim Oliu Moe, Marius Lund-Iversen, Odd Terje Brustugun
Evaluation of NTRK expression and fusions in a large cohort of early-stage lung cancer. Clinical and experimental medicine 24 (1) (2024)
Anne Pernille Harlem Dyrbekk, Abdirashid Ali Warsame, Pål Suhrke, Marianne Odnakk Ludahl, Nermin Zecic, Joakim Oliu Moe, Marius Lund-Iversen, Odd Terje Brustugun
Evaluation of NTRK expression and fusions in a large cohort of early-stage lung cancer. Clinical and experimental medicine 24 (1) (2024)
Anne Pernille Harlem Dyrbekk, Abdirashid Ali Warsame, Pål Suhrke, Marianne Odnakk Ludahl, Nermin Zecic, Joakim Oliu Moe, Marius Lund-Iversen, Odd Terje Brustugun
Evaluation of NTRK expression and fusions in a large cohort of early-stage lung cancer. Clinical and experimental medicine 24 (1) (2024)
Inger Johanne Zwicky Eide, Yngvar Nilssen, Elin Marie Stensland, Odd Terje Brustugun
Real-World Data on EGFR and ALK Testing and TKI Usage in Norway-A Nation-Wide Population Study. Cancers 15 (5) (2023)
Inger Johanne Zwicky Eide, Yngvar Nilssen, Elin Marie Stensland, Odd Terje Brustugun
Real-World Data on EGFR and ALK Testing and TKI Usage in Norway-A Nation-Wide Population Study. Cancers 15 (5) (2023)
Zeinab Kosibaty, Odd Terje Brustugun, Inger Johanne Zwicky Eide, Georgios Tsakonas, Oscar Grundberg, Luigi De Petris, Marc McGowan, Per Hydbring, Simon Ekman
Ras-Related Protein Rab-32 and Thrombospondin 1 Confer Resistance to the EGFR Tyrosine Kinase Inhibitor Osimertinib by Activating Focal Adhesion Kinase in Non-Small Cell Lung Cancer. Cancers 14 (14) (2022)
Inger Johanne Zwicky Eide, Yngvar Nilssen, Marius Lund-Iversen, Odd Terje Brustugun
Factors affecting outcome in resected EGFR -mutated lung cancer. Acta oncologica (Stockholm, Sweden) 61 (6) (2022)
Abed Agbarya, Walid Shalata, Alfredo Addeo, Andriani G Charpidou, Kristof Cuppens, Odd Terje Brustugun, Mirjana Rajer, Marco Jakopovic, Mihai Vasile Marinca, Adam Pluzanski, Thijo Jeroen N Hiltermann, Antonio Araujo
Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and Treatment. Journal of clinical medicine 11 (6) (2022)
Inger Johanne Zwicky Eide, Harald Grut, Åslaug Helland, Simon Ekman, Jens Benn Sørensen, Karin Holmskov Hansen, Bjørn Henning Grønberg, Saulius Cicenas, Jussi Pekka Koivunen, Anders Mellemgaard, Odd Terje Brustugun
Intracranial effect of osimertinib in relapsed EGFR-mutated T790M-positive and -negative non-small cell lung cancer patients: results from a phase II study. Acta oncologica (Stockholm, Sweden) 60 (12) (2021)
Odd Terje Brustugun, Yngvar Nilssen, Inger Johanne Zwicky Eide
Epidemiology and outcome of peritoneal and pleural mesothelioma subtypes in Norway. A 20 year nation-wide study. Acta oncologica (Stockholm, Sweden) 60 (10) (2021)
Jens Benn Sørensen, Pia Horvat, Mats Rosenlund, Anne Mette Kejs, Dony Patel, Ariadna Juarez-Garcia, Laure Lacoin, Melinda J Daumont, John R Penrod, John C O'Donnell, Odd Terje Brustugun, Simon Ekman
Initial treatment and survival in Danish patients diagnosed with non-small-cell lung cancer (2005-2015): SCAN-LEAF study. Future oncology (London, England) (2021)
Astri Frafjord, Renate Skarshaug, Clara Hammarström, Branislava Stankovic, Linda T Dorg, Henrik Aamodt, Per Reidar Woldbaek, Åslaug Helland, Odd Terje Brustugun, Inger Øynebråten, Alexandre Corthay
Antibody combinations for optimized staining of macrophages in human lung tumours. Scandinavian journal of immunology 92 (1) (2020)
Branislava Stankovic, Henrik Aamodt, Heidi Anine Korsmo Bjørhovde, Elisabeth Müller, Clara Hammarström, Odd Terje Brustugun, Åslaug Helland, Inger Øynebråten, Alexandre Corthay
The immune microenvironment in typical carcinoid lung tumour, a brief report of four cases. Scandinavian journal of immunology 92 (2) (2020)